ENDOREX CORP has a total of 14 patent applications. Its first patent ever was published in 1989. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are DOUCETTE-STAMM LYNN, CENTAURI THERAPEUTICS LTD and GLYCOMED INCORPORATED.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Hong Kong | 1 | |
#6 | Ireland | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Machines | |
#5 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Sugars | |
#5 | Unspecified technologies | |
#6 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Vosika Gerald J | 9 |
#2 | Ma Fanfeng | 5 |
#3 | Dean Hansi J | 4 |
#4 | Cornelius Dennis A | 3 |
#5 | Swenson Karl E | 3 |
#6 | Bucher Kyle | 2 |
#7 | Frenchick Patrick J | 2 |
#8 | Bolotin Elya | 2 |
#9 | Bucher Denise | 2 |
#10 | Fast David | 2 |
Publication | Filing date | Title |
---|---|---|
WO0076476A1 | Adjuvant-containing polymerized liposomes for oral, mucosal or intranasal vaccination | |
AU5004000A | Polymerized liposomes for the delivery of mammalian growth hormone | |
AU3006697A | Lipophile derivatives of muramylpeptides for treatment of retroviral infection and induction of chemokines | |
AU7372796A | Preparation of glucosaminyl muramic acid derivatives |